Adjusting for covariates in analysis based on restricted mean survival times

被引:2
作者
Zhong, Yi [1 ]
Zhao, Ou [2 ]
Zhang, Bo [3 ]
Yao, Bin [3 ]
机构
[1] Myovant Sci Inc, Brisbane, CA USA
[2] Loxo Oncol Lilly, 701 Gateway Blvd,Suite 350, San Francisco, CA 94080 USA
[3] Puma Biotechnol Inc, Los Angeles, CA USA
关键词
adjusted Kaplan-Meier estimator; ANCOVA; clinical trial; pseudo-observation; restricted mean survival time; HAZARDS; LIFE;
D O I
10.1002/pst.2151
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
We summarize extensions to the analysis of restricted mean survival time (RMST) in the context of time-to-event outcomes. The RMST estimate and its inference are based on the classical Kaplan-Meier curves. When covariate effects are considered, an adjusted RMST (ARMST) estimate can be derived analogously based on adjusted Kaplan-Meier curves. The adjusted Kaplan-Meier Estimator (AKME) was developed to reduce confounding by the method of inverse probability of treatment weighting. We will show how the ARMST method combines the concepts of the RMST and AKME to make inferences. Two regression based methods to adjust for potential covariate effect on the RMST estimates will be compared with the ARMST approach. Simulation studies are performed to compare the different methods with and without covariate adjustments. In addition, we will summarize the extension of RMST and ARMST to the setting with competing risks. The restricted mean time lost (RMTL) and adjusted RMTL (ARMTL) are estimates of interest from cumulative incidence curves. A phase 3 oncology clinical trial example is provided to demonstrate the applications of these methods.
引用
收藏
页码:38 / 54
页数:17
相关论文
共 34 条
  • [21] Competing Risk Regression Models for Epidemiologic Data
    Lau, Bryan
    Cole, Stephen R.
    Gange, Stephen J.
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 2009, 170 (02) : 244 - 256
  • [22] Analysis of restricted mean survival time for length-biased data
    Lee, Chi Hyun
    Ning, Jing
    Shen, Yu
    [J]. BIOMETRICS, 2018, 74 (02) : 575 - 583
  • [23] Epidemic of chronic diseases and the related healthy lifestyle interventions in rural areas of Shandong Province, China
    Lyu, Juncheng
    Zhang, Wen
    Li, Wei
    Wang, Suzhen
    Zhang, Jie
    [J]. BMC PUBLIC HEALTH, 2020, 20 (01)
  • [24] THE CENTRAL ROLE OF THE PROPENSITY SCORE IN OBSERVATIONAL STUDIES FOR CAUSAL EFFECTS
    ROSENBAUM, PR
    RUBIN, DB
    [J]. BIOMETRIKA, 1983, 70 (01) : 41 - 55
  • [25] Restricted mean survival time: an alternative to the hazard ratio for the design and analysis of randomized trials with a time-to-event outcome
    Royston, Patrick
    Parmar, Mahesh K. B.
    [J]. BMC MEDICAL RESEARCH METHODOLOGY, 2013, 13
  • [26] The use of restricted mean survival time to estimate the treatment effect in randomized clinical trials when the proportional hazards assumption is in doubt
    Royston, Patrick
    Parmar, Mahesh K. B.
    [J]. STATISTICS IN MEDICINE, 2011, 30 (19) : 2409 - 2421
  • [27] Neratinib Plus Capecitabine Versus Lapatinib Plus Capecitabine in HER2-Positive Metastatic Breast Cancer Previously Treated With ≥ 2 HER2-Directed Regimens: Phase III NALA Trial
    Saura, Cristina
    Oliveira, Mafalda
    Feng, Yin-Hsun
    Dai, Ming-Shen
    Chen, Shang-Wen
    Hurvitz, Sara A.
    Kim, Sung-Bae
    Moy, Beverly
    Delaloge, Suzette
    Gradishar, William
    Masuda, Norikazu
    Palacova, Marketa
    Trudeau, Maureen E.
    Mattson, Johanna
    Yap, Yoon Sim
    Hou, Ming-Feng
    De Laurentiis, Michelino
    Yeh, Yu-Min
    Chang, Hong-Tai
    Yau, Thomas
    Wildiers, Hans
    Haley, Barbara
    Fagnani, Daniele
    Lu, Yen-Shen
    Crown, John
    Lin, Johnson
    Takahashi, Masato
    Takano, Toshimi
    Yamaguchi, Miki
    Fujii, Takaaki
    Yao, Bin
    Bebchuk, Judith
    Keyvanjah, Kiana
    Bryce, Richard
    Brufsky, Adam
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (27) : 3138 - +
  • [28] The estimation of average hazard ratios by weighted Cox regression
    Schemper, Michael
    Wakounig, Samo
    Heinze, Georg
    [J]. STATISTICS IN MEDICINE, 2009, 28 (19) : 2473 - 2489
  • [29] Predicting the restricted mean event time with the subject's baseline covariates in survival analysis
    Tian, Lu
    Zhao, Lihui
    Wei, L. J.
    [J]. BIOSTATISTICS, 2014, 15 (02) : 222 - 233
  • [30] Competing risk bias was common in Kaplan-Meier risk estimates published in prominent medical journals
    van Walraven, Carl
    McAlister, Finlay A.
    [J]. JOURNAL OF CLINICAL EPIDEMIOLOGY, 2016, 69 : 170 - 173